Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
Mesenchymal Stem Cells, Advances and Applications
2.
Pharmacodynamic Assays Market Report
3.
Stem Cell Research Products
4.
Poly(ADP-ribose) polymerase (PARP) Research Products
5.
Advances in Biopharmaceutical Technology in India
6.
Directory of Top 60 Biopharmaceutical Manufacturers in China
7.
Directory of Top 60 Biopharmaceutical Manufacturers in India
8.
Outsourcing for contract manufacturing services 2008-2023
9.
Osteoporosis & Bone Metabolism Disorders Market 2008-2023 Management Report
10.
Pfizer - Market Outlook for a Global Leader, 2008-2013
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Autoimmune and Inflammation Rheumatoid Arthritis Drug Pipeline Report
3.
The Global Rheumatoid Arthritis Market Forecasts to 2012
4.
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, March 2008
5.
Biostatistics course
6.
Worldwide Surgical Sealants, Glues and Wound Closure Market, 2007-2011
Congestive Heart Failure: Major World Markets, Volume II: Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)
Congestive heart failure, a condition caused by a malfunctioning heart that is unable to pump enough blood and oxygen to meet the bodys needs, is an increasingly important cause of cardiovascular morbidity and mortality. With improvements in the care of other cardiac conditions, more patients have developed dilated cardiomyopathy, which is the final common pathway for many cardiac illnesses and a common cause of congestive heart failure.
Kalorama Information's Congestive Heart Failure, Major World Markets series looks at markets for CHF treatment in the United States, Europe, Japan and the Rest of the World. Volume II of this series looks at markets for device management of this disease in the following key categories:
Pacemakers
Left Ventricular Assistance Devices (LVADs)
Implantable Cardioverter/Defibrillators (ICDs)
Artificial Hearts
The report offers revenue breakdowns the following world markets:
US
Europe
Japan
Rest of World
In addition to market forecasts and current market information, this report contains a thorough review of products available on the market and profiles of key companies, including:
Abbott Laboratories
Abiomed, Inc.
Ambu, USA
Aortech International, plc
Arrow International
Atrium Medical Corporation
ATS Medical, Inc.
Bacchus Vascular, Inc.
Berlin Heart AG
Biophan Technologies, Inc.
Biosensors International
Biotronik, Inc.
Boston Scientific
CardiacAssist, Inc.
Cardiac Science Corporation
Cardiogenesis Corporation
Cordis Corporation/Biologics Delivery Systems
CoreValve, Inc.
CryoCath Technologies, Inc.
Cryocor, Inc.
Datascope
Defibtech, LLC
Deltex Medical
Heartlab
Impulse Dynamics USA, Inc.
MedicalCV, Inc.
Medtronic, Inc.
Orqis Medical Corporation
Sorin SpA
Stereotaxis, Inc.
St. Jude Medical, Inc.
Teleflex Medical
Terumo Heart, Inc.
Thoratec Corporation
Ventracor, Inc.
Volcano Corporation
As part of Kalorama Information's methodology, analyst estimates are computed with intensive research of secondary data and literature, and primary research involving interviews of experts are used to test assumptions and validate models.
Product managers, business development executives, marketing executives and planners are among those who will benefit from this resource.
February 1, 2008 250+ Pages
Table of Contents
Sample Pages (PDF)
Price
$3,500.00 Online Download
$3,900.00 Hard copy postal mail deliver
$7,000.00 Global Site Licence
$4,300.00 Online download plus 1 hard copy
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.